Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    August 2017
  1. BEN-YAKOV G, Devika K, Etzion O, Koh C, et al
    A Misleading Pattern of Serologic Findings During Hepatitis B Virus Infection.
    Ann Intern Med. 2017 Aug 29. doi: 10.7326/L17-0369.
    PubMed     Text format    


  2. KATTAKUZHY S, Gross C, Emmanuel B, Teferi G, et al
    Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
    Ann Intern Med. 2017 Aug 8. doi: 10.7326/M17-0118.
    PubMed     Text format     Abstract available


    July 2017
  3. SACKS HS
    Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response.
    Ann Intern Med. 2017;167:JC3.
    PubMed     Text format    


    June 2017
  4. KANDATHIL AJ, Breitwieser FP, Sachithanandham J, Robinson M, et al
    Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs.
    Ann Intern Med. 2017 Jun 6. doi: 10.7326/M17-0085.
    PubMed     Text format     Abstract available


    May 2017
  5. LY KN, Jiles RB, Teshale EH, Foster MA, et al
    Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014.
    Ann Intern Med. 2017 May 9. doi: 10.7326/M16-2350.
    PubMed     Text format     Abstract available


    April 2017
  6. TALAL AH, Thomas DL, Reynolds JL, Khalsa JH, et al
    Toward Optimal Control of Hepatitis C Virus Infection in Persons With Substance Use Disorders.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M16-2887.
    PubMed     Text format    


  7. BERSOFF-MATCHA SJ, Cao K, Jason M, Ajao A, et al
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M17-0377.
    PubMed     Text format     Abstract available


  8. BUCKLEY GJ, Strom BL
    A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.
    Ann Intern Med. 2017 Apr 4. doi: 10.7326/M17-0766.
    PubMed     Text format    


    March 2017
  9. HOOFNAGLE JH, Sherker AH
    Hepatitis C: Down but Not Out.
    Ann Intern Med. 2017 Mar 21. doi: 10.7326/M17-0567.
    PubMed     Text format    


  10. FALADE-NWULIA O, Suarez-Cuervo C, Nelson DR, Fried MW, et al
    Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.
    Ann Intern Med. 2017 Mar 21. doi: 10.7326/M16-2575.
    PubMed     Text format     Abstract available


  11. DI BIASE L, Picillo M, Freitas ME, Bui E, et al
    Hepatitis C Virus-Related Hepatic Myelopathy After Treatment With Sofosbuvir and Ribavirin: A Case Report.
    Ann Intern Med. 2017;166:379-380.
    PubMed     Text format    


    November 2016
  12. COLOMBO M, Aghemo A, Liu H, Zhang J, et al
    Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial.
    Ann Intern Med. 2016 Nov 15. doi: 10.7326/M16-1205.
    PubMed     Text format     Abstract available


    October 2016
  13. RABKIN CS, Goedert JJ
    Chronic Hepatitis and Non-Hodgkin Lymphoma Among People With HIV: Implications for Screening, Treatment, and Prevention.
    Ann Intern Med. 2016 Oct 18. doi: 10.7326/M16-2340.
    PubMed     Text format    


  14. WANG Q, De Luca A, Smith C, Zangerle R, et al
    Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
    Ann Intern Med. 2016 Oct 18. doi: 10.7326/M16-0240.
    PubMed     Text format     Abstract available


    September 2016
  15. KIM A
    Hepatitis C Virus.
    Ann Intern Med. 2016;165:ITC33-ITC48.
    PubMed     Text format     Abstract available


  16. EDGREN G, Hjalgrim H, Rostgaard K, Lambert P, et al
    Transmission of Neurodegenerative Disorders Through Blood Transfusion: A Cohort Study.
    Ann Intern Med. 2016;165:316-24.
    PubMed     Text format     Abstract available


    August 2016
  17. DORE GJ, Altice F, Litwin AH, Dalgard O, et al
    Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
    Ann Intern Med. 2016 Aug 9. doi: 10.7326/M16-0816.
    PubMed     Text format     Abstract available


    June 2016
  18. FREIMAN JM, Tran TM, Schumacher SG, White LF, et al
    Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2016 Jun 21. doi: 10.7326/M16-0065.
    PubMed     Text format     Abstract available


    April 2016
  19. BUCKLEY GJ, Strom BL
    What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?
    Ann Intern Med. 2016 Apr 12. doi: 10.7326/M16-0772.
    PubMed     Text format    


    March 2016
  20. MALLET V, Sberro-Soussan R, Vallet-Pichard A, Roque-Alfonso AM, et al
    Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report.
    Ann Intern Med. 2016 Mar 1. doi: 10.7326/L15-0502.
    PubMed     Text format    


    February 2016
  21. MCCANCE-KATZ EF, Valdiserri RO
    Hepatitis C Virus Treatment and Persons Who Inject Drugs.
    Ann Intern Med. 2016;164:203-4.
    PubMed     Text format    


  22. GREBELY J, Dore GJ, Greenwald R, Swan T, et al
    Hepatitis C Virus Treatment and Persons Who Inject Drugs.
    Ann Intern Med. 2016;164:203.
    PubMed     Text format    


    November 2015
  23. KOHLI A, Kattakuzhy S, Sidharthan S, Nelson A, et al
    Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial.
    Ann Intern Med. 2015 Nov 24:899-907. doi: 10.7326/M15-0642.
    PubMed     Text format     Abstract available


  24. LO RE V 3RD, Schuster M
    Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis.
    Ann Intern Med. 2015 Nov 24. doi: 10.7326/M15-2722.
    PubMed     Text format    


  25. HE T, Li K, Roberts MS, Spaulding AC, et al
    Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    Ann Intern Med. 2015 Nov 24. doi: 10.7326/M15-0617.
    PubMed     Text format     Abstract available


  26. PAUL S, Saxena A, Terrin N, Viveiros K, et al
    Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2015 Nov 24. doi: 10.7326/M15-1121.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: